Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-11-06
2007-11-06
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S831000, C424S134100, C435S007320
Reexamination Certificate
active
10876758
ABSTRACT:
A majority ofE. faecalisandE. faeciumclinical isolates fall into two groups and three groups, respectively. Distinct antigens are associate with each of the five groups. TheEnterococcusantigens are readily obtained from strains ofE. faecalisandE. faecium, and can elicit production of protective antibodies. Accordingly, the antigens are useful for vaccines which protect against infection by clinically significant (pathogenic)Enterococcusisolates. The antigens and antibodies generated to the antigens are also useful in diagnostic assays.
REFERENCES:
patent: 4439422 (1984-03-01), Swenson et al.
patent: 4579733 (1986-04-01), Kawai et al.
patent: 4687764 (1987-08-01), Kawai et al.
patent: 4692417 (1987-09-01), Webster
patent: 4695624 (1987-09-01), Marburgh
patent: 4710379 (1987-12-01), Kawai et al.
patent: 4761283 (1988-08-01), Anderson
patent: 4797278 (1989-01-01), Kawai et al.
patent: 4801578 (1989-01-01), Monsigny
patent: 5032505 (1991-07-01), Pierce et al.
patent: 5143845 (1992-09-01), Masuda
patent: 5225331 (1993-07-01), Jennings
patent: 5478557 (1995-12-01), Nisbet et al.
patent: 5601999 (1997-02-01), Matsuzaki et al.
patent: 5623057 (1997-04-01), Marburg et al.
patent: 5695768 (1997-12-01), Malcolm
patent: 5700787 (1997-12-01), Tzianabos et al.
patent: 5741495 (1998-04-01), Jamas et al.
patent: 5760213 (1998-06-01), Ooiso et al.
patent: 5861157 (1999-01-01), Burnie et al.
patent: 5871751 (1999-02-01), Christensen et al.
patent: 5878747 (1999-03-01), Enomoto et al.
patent: 5989542 (1999-11-01), Pier et al.
patent: 6355625 (2002-03-01), Pavliak et al.
patent: 6428793 (2002-08-01), Semprevivo
patent: 6489302 (2002-12-01), Wiessler et al.
patent: 6720160 (2004-04-01), Wolde-Mariam
patent: 6722062 (2004-04-01), Pier et al.
patent: 6756361 (2004-06-01), Fattom et al.
patent: 7030101 (2006-04-01), Pavliak et al.
patent: 132 981 (1985-02-01), None
patent: 08-027010 (1996-01-01), None
patent: 2101029 (1998-01-01), None
patent: 87/00531 (1987-01-01), None
patent: WO 99/08705 (1999-02-01), None
Bleiweis, AS et al, J. Bacteriology, Nov. 1967, vol. 94, pp. 1381-1387, Cell Walls of Group D Streptococci.
Heidelberger, Michael, Molecular Immunology, vol. 21(11) pp. 1011-1013, 1984, Cross reactions of polysaccharides of staphylococci and streptococci in antipneumonoccal and other bacteria (entire article).
Kessler, RE et al, Infection and Immunity (1984, reference of record).
Elliott, SD et al, (1977, reference of record).
Maekawa, S et al, Microbial Immunol. 1992, vol. 36(7), pp. 671-681, Proposal of a New Schene for the Serological Typing ofEnterococcus faecalisstrains.
Puzur, JH e tal, The Journal of Biological Chemistry, vol. 246(6), Mar. 25, 1971, pp. 1793-1798, Glycans from Streptococcal Cell Walls( reference of record).
Hufnagel, Markus et al, Clinical and Diagnostic Laboratory Immunology, Aug. 2005, vol. 12(6), pp. 930-934, Naturally acquired antibodies against FourEnterococcus faecaliscapsular polysaccharides in Healthy Human sera.
Supplementary Partial European Search Report No. 98 95 1058, dated Jan. 8, 2003.
Pritchard, David G., et al., “Carbohydrate Fingerprints of Streptococcal Cells,” Journal of Clinical Microbiology, Jan. 1981, pp. 89-92, vol. 13, No. 1.
Fattom, Ali, et al., “Laboratory and Clinical Evaluation of Conjugate Vaccines Composed of Staphylcoccus Aureus Type 5 and Type 8 Capsular Polysaccharides Bound toPseudomonas aeruginosaRecombinant Exoprotein A,” Infection and Immunity, Mar. 1993, pp. 1023-1032, vol. 61, No. 3.
Naso, Robert, et al. “Polysaccharide Conjugate Vaccines for the Prevention of Gram-Positive Bacterial Infections,” Advances in Experimental Medicine and Biology, pp. 133-140, vol. 397, 1996.
Heidelberg, M., Molecular Immunology, Nov. 1984, vol. 21(11), pp. 1011-1013, (abstract).
Pazur, JH et al., Journal of Immunological Methods, Dec. 14, 1984, vol. 75(1), pp. 107-116 (abstract only).
Yakushiji, K.K. et al., Oral Microbial Immunology, vol. 8, pp. 161-166, 1993.
Naso, R. et al., Advances in Experimental Medicine and Biology, vol. 397, pp. 133-138 (abstract), date unknown.
Moreau, M. et al., Oct. 15, 1988, Carbohydrate Res., vol. 182(1), pp. 79-99.
Wessman, GE, Infection Immunity, Jul. 1975, vol. 12(1), pp. 156-161.
Aluyi, HS et al, J. Appl. Bacteriol., Jun. 1983, vol. 54(3), pp. 391-397.
Pazure, J.H. et al., Glycans from Streptococcal Cell Walls, The Journal of Biological Chemistry, Mar. 25, 1971, vol. 246, No. 6, pp. 1793-1798, see abstract and entire document.
Amvam-Zollo, P. et al., Streptococcus pneumoniae type XIV polysaccharide: synthesis of a repeating branched tetrasaccharide with dioxa-type spacer-arms, Carbohydrate Research, 1986, vol. 150, pp. 199-212.
Guzman, C.A. et al. Serum Dependent Expression ofenterococcus faecalisadhesions involved in the colonization of heart cells; Microbial Pathology, 1991, vol. 11, No. 60, pp. 399-409, p. 406, 1stparagraph.
Kessler, R.E., Interaction of anti-kojibiose antibody with the lipoteichoic acids fromStreptococcus faecalisandStreptococcus faecium; Infection and Immunity; 10/19 vol. 46, No. 1, pp. 279-281, see entire doc.
Pazur, J.H. et al., Determination of the sugar sequences and the glycosidic-bond arranges of immunogenic heteroglycans, Carbohydrate Research, 1978, vol. 60, pp. 167-178, No. 1, especially abstract.
Elliott, S.D. et al., Telchoic Acids of Group D Streptococci with special reference to strains from pig meningitis, Journal of Experimental Medicine, 1977, vol. 145, No. 3, pp. 490-499, especially 499, first paragraph 2.
Dick, W.E., Jr et al., Glycoconjugates of bacterial carbohydrate antigens, Contributions to Microbiology and Immunology, Conjugate vaccines, 1989, vol. 10, pp. 48-114, see entire document.
Fattom Ali Ibrahim
Shepherd Sara E.
Sood Ramesh K.
Foley & Lardner LLP
Nabi Biopharmaceuticals
Navarro Mark
Portner Ginny Allen
LandOfFree
Enterococcus antigens and vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enterococcus antigens and vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enterococcus antigens and vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3888803